Page 12 - CIRN Annual Report 2017

uenza surveillance.
Also, SOS data have been used for secondary data analysis of the
cost of influenza hospitalization across Canada. SOS continues
Invasive Pneumococcal Disease. Since 2015, CIHR/PHAC has

provided additional targeted funding for SOS infl

~8000 adult acute-care beds.

to provide real-time influenza and CAP surveillance data for 2017, providing invaluable data to PHAC and provincial agencies. The network is comprised of 13 sites located in BC, Ontario, Quebec, New Brunswick, and Nova Scotia. Currently, 15 hospitals in 5 provinces participate in the network’s activities, providing data on

Over the past year, the Serious Outcomes Surveillance (SOS)
activity weekly to the Public Health Agency of Canada (PHAC), and
uenza uenza
Network has demonstrated its continuing value as a real-time
Established in 2009, the SOS Network prospectively monitors
annual seasonal influenza vaccine effectiveness (VE) in the
rmed infl
Serious Outcomes
Surveillance (SOS)

illness, and is also examining the burden of influenza illness to the health care system among adults hospitalized by this disease. SOS has successfully leveraged funding from Pfizer in order to continue surveillance of Community Acquired Pneumonia and

Network reporter of vaccine effectiveness, reporting on national infl adding provincial estimates for INSPQ. prevention of hospitalization of adults with confi 10